These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells. Asghari V; Wang JF; Reiach JS; Young LT Brain Res Mol Brain Res; 1998 Jul; 58(1-2):95-102. PubMed ID: 9685595 [TBL] [Abstract][Full Text] [Related]
3. Increase in AP-1 transcription factor DNA binding activity by valproic acid. Chen G; Yuan P; Hawver DB; Potter WZ; Manji HK Neuropsychopharmacology; 1997 Mar; 16(3):238-45. PubMed ID: 9138440 [TBL] [Abstract][Full Text] [Related]
4. Lithium stimulates gene expression through the AP-1 transcription factor pathway. Yuan PX; Chen G; Huang LD; Manji HK Brain Res Mol Brain Res; 1998 Jul; 58(1-2):225-30. PubMed ID: 9685653 [TBL] [Abstract][Full Text] [Related]
5. Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo. Yuan P; Chen G; Manji HK J Neurochem; 1999 Dec; 73(6):2299-309. PubMed ID: 10582587 [TBL] [Abstract][Full Text] [Related]
6. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. Chen G; Huang LD; Jiang YM; Manji HK J Neurochem; 1999 Mar; 72(3):1327-30. PubMed ID: 10037507 [TBL] [Abstract][Full Text] [Related]
7. Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos. Chen B; Wang JF; Hill BC; Young LT Brain Res Mol Brain Res; 1999 Jun; 70(1):45-53. PubMed ID: 10381542 [TBL] [Abstract][Full Text] [Related]
8. Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells. Pacheco MA; Jope RS Brain Res Mol Brain Res; 1999 Oct; 72(2):138-46. PubMed ID: 10529472 [TBL] [Abstract][Full Text] [Related]
9. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line. Farrelly LA; Savage NT; O'Callaghan C; Toulouse A; Yilmazer-Hanke DM Regul Pept; 2013 Sep; 186():123-30. PubMed ID: 23994577 [TBL] [Abstract][Full Text] [Related]
11. Valproate and neuroprotective effects for bipolar disorder. Atmaca M Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154 [TBL] [Abstract][Full Text] [Related]
12. Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-kappaB DNA binding activity and COX-2 mRNA. Rao JS; Bazinet RP; Rapoport SI; Lee HJ Bipolar Disord; 2007 Aug; 9(5):513-20. PubMed ID: 17680922 [TBL] [Abstract][Full Text] [Related]
13. Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. Bachmann RF; Wang Y; Yuan P; Zhou R; Li X; Alesci S; Du J; Manji HK Int J Neuropsychopharmacol; 2009 Jul; 12(6):805-22. PubMed ID: 19149911 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene. Manna PR; Eubank DW; Stocco DM Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133 [TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Zhao Y; Nichols JE; Valdez R; Mendelson CR; Simpson ER Mol Endocrinol; 1996 Nov; 10(11):1350-7. PubMed ID: 8923461 [TBL] [Abstract][Full Text] [Related]
16. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393 [TBL] [Abstract][Full Text] [Related]
17. Two proximal activating protein-1-binding sites are sufficient to stimulate transcription of the ovine follicle-stimulating hormone-beta gene. Strahl BD; Huang HJ; Pedersen NR; Wu JC; Ghosh BR; Miller WL Endocrinology; 1997 Jun; 138(6):2621-31. PubMed ID: 9165057 [TBL] [Abstract][Full Text] [Related]
18. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795 [TBL] [Abstract][Full Text] [Related]
19. Identification of a novel SP3 binding site in the promoter of human IGFBP4 gene: role of SP3 and AP-1 in regulating promoter activity in CaCo2 cells. Shen Q; Singh P Oncogene; 2004 Apr; 23(14):2454-64. PubMed ID: 14767471 [TBL] [Abstract][Full Text] [Related]
20. Valproic acid-mediated transcriptional regulation of human GM3 synthase (hST3Gal V) in SK-N-BE(2)-C human neuroblastoma cells. Kwon HY; Kang NY; Dae HM; Kim KS; Kim CH; Do SI; Lee Y Acta Pharmacol Sin; 2008 Sep; 29(9):999-1005. PubMed ID: 18718167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]